Cecile Magis-Escurra (C Magis-Escurra)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Prognostic Factors

Mycobacterium Tuberculosis

Top Venues

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Rosarito Coronel Teixeira, D IJdema, C Gómez, D Arce, M Roman, Y Quintana, F González, N Jiménez de Romero, D Pérez Bejarano, S Aguirre, Cecile Magis-Escurra
The electronic nose as a rule-out test for tuberculosis in an indigenous population. Journal of internal medicine 290 (2) (2021)